GMA Medical Research

Publication Expected Early 2018
Replication Metabolomics Study in CFS with Paul Cheney MD
Published Study - August 2016
Metabolic features of chronic fatigue syndrome

Our Metabolomics study on Chronic Fatigue Syndrome was published August 2016 in the Proceedings of the National Academay of Sciences (PNAS), one of the most prestigious medical journals in the US and the world. This ground breaking study is changing the way chronic illness, and Chronic Fatigue Syndrome in particular will be understood and treated.

Chronic fatigue syndrome is a multisystem disease that causes long-term pain and disability. It is difficult to diagnose because of its protean symptoms and the lack of a diagnostic laboratory test. We report that targeted, broad-spectrum metabolomics of plasma not only revealed a characteristic chemical signature but also revealed an unexpected underlying biology. Metabolomics showed that chronic fatigue syndrome is a highly concerted hypometabolic response to environmental stress that traces to mitochondria and was similar to the classically studied developmental state of dauer. This discovery opens a fresh path for the rational development of new therapeutics and identifies metabolomics as a powerful tool to identify the chemical differences that contribute to health and disease.

Read the full study

Metabolomics Q&A for CFS v6

From the Neurohacker Collective Insights Podcast

Discussion on Metablomics bewteen Nafysa Parpia, ND and Daniel Schmachtenberger

Patient receiving IV treatment -1200 - Maggie Perkins 2017

Gordon Medical has been actively doing research into Chronic Fatigue Syndrome (CFS/ME), Multiple Chemical Sensitivity (MCS), and chronic Lyme Disease since 2005. We are now also partnering with researchers at Stanford University, along with several groups working to improve collecting and processing patient history and outcome data. In 2014 we established Science in Service of Humanity to be our research arm, and in 2016 we founded the Gordon Medical Research Center, a non-profit fundraising corporation that would allow tax deductible donations to support our research.